OneSource Specialty Pharma Limited has secured in-principle approval from the Government of Karnataka for its Unit II expansion project. This initiative, supported by the Karnataka Industrial Policy (KIP) 2025–30, aims to boost the company’s manufacturing capacity at its Obadenahalli facility. The proposal, reviewed during the 67th State High Level Clearance Committee meeting on April 13, 2026, marks a pivotal step in the firm’s growth strategy to better serve its international client base.
Strategic Expansion of Flagship Facility
OneSource Specialty Pharma Limited is set to scale its operations at its flagship Unit II facility. Located at the KIADB Industrial Area in Obadenahalli, Doddaballapur Taluk, this expansion is designed to enhance the company’s production capabilities. The move is a core component of the firm’s overarching growth strategy, intended to strengthen its manufacturing footprint and improve service delivery for global partners.
Approval and Policy Support
The project has received formal in-principle approval under the Karnataka Industrial Policy (KIP) 2025–30, which provides the company with access to various incentives and concessions. The authorization was granted following the 67th State High Level Clearance Committee (SHLCC) meeting held on April 13, 2026. The formal Government Order, bearing No. CI 120 SPI 2026, was issued on May 12, 2026, and subsequently received by the company on May 15, 2026.
Source: BSE
